Access to Medicine Foundation
The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Access to Medicine Index
Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.
Antimicrobial Resistance Benchmark
Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.
Access to Vaccines Index
Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Download the full research reports and methodologies from the Foundation's three research programmes, as well as studies, articles and briefing papers on how pharmaceutical companies address specific access-to-medicine priorities.
published on 06 Feb 2017
Learn more
published on 10 Oct 2016
published on 02 Aug 2016
published on 17 Mar 2016
published on 29 Feb 2016
published on 19 Feb 2016
published on 24 Nov 2015
published on 20 Oct 2015
published on 23 Sep 2015
Back to top |
